A polymorphism in the presenilin 1 gene does not modify risk for Alzheimer's disease in a cohort with sporadic early onset

Neuroscience Letters

Volumn 228, Issue 3, 1997, Pages 212-214

  Lendon, Corinne L ^a   Myers, Amanda ^a   Cumming, Alistair ^b   Goate, Alison M ^a   St Clair, David ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Alzheimer's disease; Association study; Early onset; Presenilin; Sporadic

Indexed keywords

PRESENILIN 1;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DNA; FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRESENILIN-1; RISK; SCOTLAND;

EID: 0030967695     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00393-5     Document Type: Article

References (11)

1. Corder E., Saunders A., Strittmatter W., Schmechel D., Gaskell P., Small G., Roses A., Haines J., Pericak-Vance M. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
2. Cumming A.M., Robertson F.W. Polymorphism at the apolipoprotein E locus in relation to risk for coronary heart disease. Clin. Genet. 25:1984;310-313.
3. Higuchi S., Muramatsu T., Matsushita S., Arai H., Saski H. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1185-1186.
4. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J. Lipid Res. 31:1990;545-548.
5. Kehoe P., Williams J., Lovestone S., Wilcock G., Owen M.J. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1185.
6. Lendon C.L., Ashall F., Goate A.G. Exploring the etiology of Alzheimer's disease using molecular genetics. J. Am. Med. Assoc. 277:(10):1997;825-831.
7. Perez-Tur J., Wavrant-De Vriezem F., Lambert J.C., Chartier-Harlin M.C. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1560-1561.
8. Scott W.K., Growdon J.H., Roses A.D., Pericak-Vance M.A. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 347:1996;1186-1187.
9. St. Clair D., Rennie M., Slorach E., Norrman J., Yates C., Carothers A. Apolipoprotein E ε4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers. J Med. Genet. 32:1995;642-644.
10. van Duijn C., de Knijff P., Wehnert A., Havekes L., Hofman A., van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early onset Alzheimer's disease. Nature Genet. 7:(1):1994;74-78.
11. Wragg M., Hutton M., Talbot C.J., Busfield F., Han S.W., Lendon C.L., Clark R., Morris J.C., Edwards D., Pfeiffer E., Rossor M., Crook R., Prihar G., Philips H., Baker M., Houlden H., Roberts G., Karran E., Craddock N., Goate A.M., Hardy J. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet. 347:1996;509-512.